Unknown

Dataset Information

Metformin, A Potential Role in Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis.


ABSTRACT:

Background

Currently, no generally approved medical treatment can delay the onset of age-related macular degeneration (AMD) or slow the progression of degenerative changes. Repurposing drugs with beneficial effects on AMD pathophysiology offers a route to new treatments which is faster, cost-effective, and safer for patients. Recent studies indicate a potential role for metformin in delaying AMD development and progression. In this context, we conducted a systematic review and meta-analysis to look for beneficial associations between metformin and AMD.

Methods

We systematically searched Medline and Embase (via Ovid), Web of Science, and ClinicalTrials.gov databases for clinical studies in humans that examined the associations between metformin treatment and AMD published fro

SUBMITTER: Romdhoniyyah DF 

PROVIDER: S-EPMC8079568 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature